The 5-Year Follow-Up Results of the C5r Protocol With Rituximab and Intrathecal Liposomal Cytarabine for Primary CNS Lymphoma: A Prospective Phase 2 Study of the Lysa

Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_61
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Bendamustine and Rituximab in Elderly Patients With Low-Tumour Burden Follicular Lymphoma. Results of the LYSA Phase II BRIEF Study

British Journal of Haematology
Hematology
2018English

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma

Neurology
Neurology
2011English

Ibrutinib in Relapse or Refractory Primary CNS and Vitreo-Retinal Lymphoma. Results of the Primary End-Point of the I Loc Phase Ii Study From the Lysa and the French Loc Network.

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Poor Results With the Shuttle Stop: Resorbable Versus Nonresorbable Intramedullar Cement Restrictor in a Prospective and Randomized Study With a 2-Year Follow-Up

Acta Orthopaedica Scandinavica
2003English

Quality of Life in Patients With Proton-Treated Pediatric Medulloblastoma: Results of a Prospective Assessment With 5-Year Follow-Up

Cancer
Cancer ResearchOncology
2018English

Does Therapy of the Primary Tumor Matter in Oligometastatic Prostate Cancer? A Prospective 10-Year Follow-Up Study

Research and Reports in Urology
Urology
2019English

Study Protocol, Sample Characteristics, and Loss to Follow-Up: The OPPERA Prospective Cohort Study

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2013English

Radioimmunotherapy for Mantle Cell Lymphoma: 5-Year Follow-Up of 90 Patients From the International RIT Registry

Annals of Hematology
MedicineHematology
2020English

A 5-Year Follow-Up Study of 117 Battered Women.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy